Oncology PracticeData emerging to support personalized nutrition in oncologyFebruary 8, 2020Breast CancerCNS/Brain CancerPreventive Care
Oncology PracticeGlobal project reveals cancer’s genomic playbookFebruary 5, 2020Mixed TopicsCNS/Brain CancerBreast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersGynecologic Cancer
Oncology PracticeQoL good for MGMT-methylated glioblastoma patients with lomustine-temozolideJanuary 2, 2020CNS/Brain CancerNeuro-oncologyPatient & Survivor Care
Oncology PracticeIORT boosts local control, survival of glioblastomaDecember 30, 2019CNS/Brain Cancer
Oncology PracticeHER2-mutant NSCLC confers high brain metastases riskSeptember 5, 2019Lung CancerCNS/Brain Cancer
Oncology PracticeDrug-inducible gene therapy unlocks IL-12 for glioblastomaAugust 14, 2019CNS/Brain Cancer
Oncology PracticeInvestigators target brain metastases in NSCLCJuly 16, 2019Lung CancerCNS/Brain Cancer
Oncology PracticeFDA approves bevacizumab-bvzr for several cancersJune 28, 2019Gynecologic CancerRenal Cell CarcinomaLung CancerGastroenterologyGenitourinary CancerCNS/Brain CancerNeuro-oncology
Oncology PracticeEHR default order slashes unnecessary imaging during palliative RTJune 28, 2019Practice ManagementCNS/Brain CancerSarcoma & GIST
Oncology PracticeTrial matches pediatric cancer patients to targeted therapiesMay 31, 2019Sarcoma & GISTPediatricsRenal Cell CarcinomaCNS/Brain CancerGenitourinary CancerPediatric Neuroblastoma
Oncology PracticeEntrectinib exhibits activity in children with solid tumorsMay 23, 2019CNS/Brain CancerPediatricsMelanomaSarcoma & GISTPediatric Neuroblastoma
Oncology PracticeLiquid biopsy falls short for isolated brain lesions in lung cancerApril 16, 2019Lung CancerCNS/Brain CancerNeuro-oncology
Oncology PracticeMRI predicts ALK status of NSCLC via brain lesionsApril 11, 2019Lung CancerCNS/Brain Cancer
Oncology PracticeCombo shows promise in HER2-positive breast cancer with brain metsMarch 15, 2019Breast CancerCNS/Brain Cancer
Oncology PracticeFDA Expanded Access benefits heavily pretreated patients, especially childrenMarch 4, 2019Practice ManagementCNS/Brain CancerBreast CancerLung CancerBusiness of Medicine
